JAMA Internal Medicine

OCTOBER 6, 2024

This crossover randomized clinical trial aims to determine the effect of different arm positions on blood pressure readings.

Clinical Trials 104

Clinical Trials Clinical Trials Trials 104

pharmaphorum

OCTOBER 6, 2024

Recent financings in the digital health sector include a $73 million round for artificial intelligence-enabled robotics player Mendaera, with Qure.ai, VieCure, Rippl, and Univa Health also raising money.Silicon Valley startup Mendaera has earmarked the Series B funding to complete the development of its handheld robotics, medical imaging and AI platform, which is intended for use in commonplace medical procedures like taking biopsies, organ and vascular access, and pain management.

Development 91

Development 91

JAMA Internal Medicine

OCTOBER 6, 2024

This randomized clinical trial examines the effect of a benzodiazepine taper plus augmented cognitive behavioral therapy for insomnia program vs an unmasked taper plus standard cognitive behavioral therapy for insomnia.

Clinical Trials 53

Clinical Trials Clinical Trials Trials 53

pharmaphorum

OCTOBER 6, 2024

Activist investor Starboard Value has amassed a $1bn stake in pharma group Pfizer and wants strategic changes to restore growth

64

64

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Patent Watch

OCTOBER 6, 2024

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … Source

Drugs 52

Drugs 52